We are live on
!
Find out more
Pictet Asset Management Portfolio holdings
AUM
$105B
1-Year Est. Return
38.07%
This Fund
S&P 500
This Quarter
Est. Return
-2.69%
1 Year Est. Return
+38.07%
3 Year Est. Return
+113.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$90B
AUM Growth
-$2.64B
(-2.9%)
Cap. Flow
+$2.07B
Cap. Flow
% of AUM
2.3%
Top 10 Holdings %
Top 10 Hldgs %
17.41%
Holding
2,101
New
60
Increased
1,058
Reduced
623
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$327M |
| 2 |
Broadcom
AVGO
|
+$315M |
| 3 |
Mastercard
MA
|
+$262M |
| 4 |
Intuit
INTU
|
+$226M |
| 5 |
Digital Realty Trust
DLR
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$169M |
| 3 |
WCN
Waste Connections
WCN
|
+$141M |
| 4 |
NextEra Energy
NEE
|
+$134M |
| 5 |
Cadence Design Systems
CDNS
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.36% |
| 2 | Industrials | 16.63% |
| 3 | Healthcare | 13.3% |
| 4 | Financials | 8.12% |
| 5 | Consumer Discretionary | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
NextDecade
NEXT
$1.8B
| $265K | ﹤0.01% |
33,568
-2,853
| -8% | -$23K |
|
1677
Kulicke & Soffa
KLIC
$4.76B
| $265K | ﹤0.01% |
8,034
| – | – |
|
1678
Progyny
PGNY
$2.04B
| $265K | ﹤0.01% |
11,856
| – | – |
|
1679
Powell Industries
POWL
$7.59B
| $265K | ﹤0.01% |
4,665
+444
| +11% | +$30.9K |
|
1680
PBF Energy
PBF
$8.22B
| $265K | ﹤0.01% |
13,874
| – | – |
|
|
LINE
1681
Lineage Inc
LINE
$9.52B
| $265K | ﹤0.01% |
4,515
-6,497
| -59% | -$379K |
|
1682
Levi Strauss
LEVI
$8.75B
| $264K | ﹤0.01% |
16,910
+6,635
| +65% | +$115K |
|
1683
Leonardo DRS
DRS
$11.9B
| $263K | ﹤0.01% |
8,010
-5
| -0.1% | -$165 |
|
|
UMH
1684
UMH Properties
UMH
$1.38B
| $263K | ﹤0.01% |
14,082
-7,923
| -36% | -$144K |
|
1685
Warby Parker
WRBY
$3.1B
| $262K | ﹤0.01% |
14,391
+4,205
| +41% | +$100K |
|
1686
LiveRamp
RAMP
$2.3B
| $262K | ﹤0.01% |
10,030
+1,171
| +13% | +$35.8K |
|
|
AIV
1687
Aimco
AIV
$376M
| $261K | ﹤0.01% |
29,629
-12,524
| -30% | -$111K |
|
|
XHR
1688
Xenia Hotels & Resorts
XHR
$1.72B
| $260K | ﹤0.01% |
22,122
-11,634
| -34% | -$162K |
|
1689
Argan
AGX
$8.11B
| $259K | ﹤0.01% |
1,978
+491
| +33% | +$68.5K |
|
1690
Certara
CERT
$1.24B
| $259K | ﹤0.01% |
26,204
+14,308
| +120% | +$174K |
|
|
NTST
1691
NETSTREIT Corp
NTST
$2.02B
| $259K | ﹤0.01% |
16,367
-4,711
| -22% | -$68.9K |
|
1692
LeMaitre Vascular
LMAT
$1.89B
| $259K | ﹤0.01% |
3,090
+366
| +13% | +$34K |
|
1693
Magnite
MGNI
$3.49B
| $258K | ﹤0.01% |
22,641
+2,238
| +11% | +$35.7K |
|
1694
National Bank Holdings
NBHC
$1.92B
| $258K | ﹤0.01% |
+6,750
| New | +$281K |
|
|
PINC
1695
DELISTED
Premier
PINC
| $258K | ﹤0.01% |
13,380
| – | – |
|
1696
Amkor Technology
AMKR
$13.5B
| $258K | ﹤0.01% |
14,270
| – | – |
|
1697
Ambarella
AMBA
$3.64B
| $258K | ﹤0.01% |
5,117
+474
| +10% | +$32.4K |
|
1698
Banco Santander Chile
BSAC
$16.5B
| $256K | ﹤0.01% |
11,221
| – | – |
|
1699
United Natural Foods
UNFI
$2.86B
| $255K | ﹤0.01% |
9,326
+1,079
| +13% | +$31.3K |
|
1700
Liberty Live Group Series A
LLYVA
$9.25B
| $254K | ﹤0.01% |
3,780
+80
| +2% | +$5.58K |
|
Similar funds
Pictet Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, Pictet Asset Management held 2,101 positions worth $90B, down 2.9% from $92.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Pictet Asset Management's Q1 2025 filing shows 60 new, 1,058 increased, 623 reduced and 92 closed positions. Its largest new stake was Verona Pharma: 703,063 shares worth $44.6M. The largest sale was Intra-Cellular Therapies Inc., an estimated $187M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Industrials and Healthcare.
- Pictet Asset Management's largest Q1 2025 buy was Verona Pharma: 703,063 shares worth $44.6M.
- Pictet Asset Management added most to Synopsys in Q1 2025, an estimated $327M increase.
- Pictet Asset Management's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $187M.
- Pictet Asset Management fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q1 2025, selling an estimated $46.5M.
- Pictet Asset Management's ten largest holdings make up 17% of its $90B portfolio in Q1 2025.
- Pictet Asset Management opened 60 new positions and closed 92 in Q1 2025.
- Pictet Asset Management's portfolio value fell 2.9% quarter-over-quarter to $90B.
Based on Pictet Asset Management's 13F filing for Q1 2025, filed 5 May 2025.